Is Trigyn Techno. overvalued or undervalued?

As of 22 September 2025, the valuation grade for Trigyn Technologies has moved from expensive to very expensive, indicating a significant deterioration in its perceived value. The company is currently overvalued, with a PE ratio of -286.31, an EV to EBITDA of -17.90, and a Price to Book Value of 0.39. These ratios suggest that the company's financial metrics are not only poor but also reflect a lack of profitability and sustainability in its operations.
When compared to peers, Trigyn's valuation stands in stark contrast to companies like TCS, which has a PE ratio of 22.58 and an EV to EBITDA of 15.91, and Infosys, with a PE of 22.86 and an EV to EBITDA of 15.02. This highlights how Trigyn is not only underperforming relative to its industry but also raises concerns about its long-term viability. Despite recent stock performance showing a 28.06% return over the past week, this does not mitigate the overall valuation concerns, especially given the negative returns over the longer term compared to the Sensex.